• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精后妊娠静脉血栓栓塞发病率增加。

Increased venous thrombosis incidence in pregnancies after in vitro fertilization.

机构信息

Centre of Haemophilia and Thrombosis, Department of Clinical Biochemistry, Aarhus University Hospital, Brendstrupgaardsvej 100, Aarhus N 8200, Denmark.

出版信息

Hum Reprod. 2014 Mar;29(3):611-7. doi: 10.1093/humrep/det458. Epub 2014 Jan 6.

DOI:10.1093/humrep/det458
PMID:24399508
Abstract

STUDY QUESTION

Is venous thrombosis risk increased in pregnancies after in vitro fertilization?

SUMMARY ANSWER

The venous thrombosis incidence was significantly increased in pregnancies after in vitro fertilization; especially in the first trimester and in the first 6 weeks post-partum.

WHAT IS KNOWN ALREADY

In vitro fertilization without pregnancy is not associated with increased venous thrombosis incidence.

STUDY DESIGN, SIZE, DURATION: This national register-based cohort study covered the period from 1995 to 2005.

PARTICIPANTS/MATERIALS, SETTING, METHODS: All Danish pregnancies conceived by in vitro fertilization (n = 18 787) were included. Venous thrombosis incidence rates in pregnancies after in vitro fertilization were compared with venous thrombosis incidence rates in reference pregnancies, by calculating incidence rate ratios.

MAIN RESULTS AND THE ROLE OF CHANCE

In total, 48 cases were identified. In pregnancies after in vitro fertilization, the overall venous thrombosis incidence rate was 28.6 per 10 000 pregnancy-years (95% confidence interval (CI) 20.6-39.6) in comparison to 10.7 per 10 000 woman-years in reference pregnancies. Post-partum, the venous thrombosis incidence rate was 27.9 per 10 000 woman-years (95% CI 15.8-49.1) after in vitro fertilization in comparison to 17.5 per 10 000 woman-years in reference pregnancies. The overall venous thrombosis incidence rate ratio during in vitro fertilization (IVF) pregnancies compared with reference pregnancies was 3.0 (95% CI 2.1-4.3). The venous thrombosis incidence rate ratios during pregnancy were 2.8 (95% CI 1.9-4.1) in singleton IVF pregnancies and 4.4 (95% CI 2.4-8.3) in multiple IVF pregnancies, compared with reference pregnancies. The venous thrombosis incidence rate ratio post-partum was 1.2 (95% CI 0.6-2.8) for singleton IVF pregnancies and 3.9 (95% CI 1.7-8.8) for multiple IVF pregnancies compared with reference pregnancies. The post-partum venous thrombosis risk was higher in multiple IVF pregnancies compared with singleton IVF pregnancies. Maternal age, smoking and parity did not significantly affect the venous thrombosis risk. Ovarian hyperstimulation syndrome and polycystic ovarian syndrome did increase the risk of venous thrombosis during pregnancy. Caesarean section also increased the post-partum venous thromboembolism risk, but the increase was not significant.

LIMITATIONS, REASONS FOR CAUTION: Other known confounders in our reference population could have contributed to the results. Access to such data may have helped to explain the observations, but would not have changed the conclusion that IVF pregnancies have an increased risk of venous thrombosis compared with other pregnancies.

WIDER IMPLICATIONS OF THE FINDINGS

Our study adds new insights by demonstrating an excess venous thrombosis incidence post-partum after in vitro fertilization. The high venous thrombosis incidence in first trimester after in vitro fertilization supports previous studies. Our findings are generalizable to other Western Countries.

STUDY FUNDING/COMPETING INTERESTS: Expenses for the acquirement of data were covered by a grant from The Secretary of Doctors further education, Central Denmark Region. None of the authors have any competing interests to declare.

TRIAL REGISTRATIONS NUMBER

Not applicable.

摘要

研究问题

体外受精后妊娠的静脉血栓形成风险是否增加?

总结答案

体外受精后妊娠的静脉血栓形成发生率显著增加;尤其是在妊娠早期和产后 6 周内。

已知情况

体外受精而未妊娠与静脉血栓形成发生率增加无关。

研究设计、大小、持续时间:本全国登记队列研究涵盖了 1995 年至 2005 年期间。

参与者/材料、设置、方法:纳入所有通过体外受精(IVF)受孕的丹麦妊娠(n=18787)。通过计算发病率比值,比较体外受精后妊娠的静脉血栓形成发生率与参考妊娠的静脉血栓形成发生率。

主要结果和机会的作用

总共确定了 48 例病例。与参考妊娠相比,体外受精后妊娠的总体静脉血栓形成发生率为每 10000 妊娠年 28.6(95%置信区间[CI]20.6-39.6),而参考妊娠为每 10000 妇女年 10.7。产后,与参考妊娠相比,体外受精后产后静脉血栓形成发生率为每 10000 妇女年 27.9(95%CI15.8-49.1)。与参考妊娠相比,体外受精(IVF)妊娠期间的总体静脉血栓形成发生率比值为 3.0(95%CI2.1-4.3)。与参考妊娠相比,单胎 IVF 妊娠期间的静脉血栓形成发生率比值为 2.8(95%CI1.9-4.1),多胎 IVF 妊娠期间的静脉血栓形成发生率比值为 4.4(95%CI2.4-8.3)。与参考妊娠相比,单胎 IVF 妊娠产后静脉血栓形成发生率比值为 1.2(95%CI0.6-2.8),多胎 IVF 妊娠产后静脉血栓形成发生率比值为 3.9(95%CI1.7-8.8)。与单胎 IVF 妊娠相比,多胎 IVF 妊娠产后静脉血栓形成风险更高。产妇年龄、吸烟和产次并没有显著影响静脉血栓形成风险。卵巢过度刺激综合征和多囊卵巢综合征会增加妊娠期间静脉血栓形成的风险。剖宫产也会增加产后静脉血栓栓塞的风险,但增加不显著。

局限性、谨慎的原因:我们参考人群中的其他已知混杂因素可能导致了结果。获得这些数据可能有助于解释观察结果,但不会改变与其他妊娠相比,体外受精妊娠的静脉血栓形成风险增加的结论。

研究结果的更广泛意义

我们的研究通过证明体外受精后产后静脉血栓形成发生率增加提供了新的见解。体外受精后妊娠早期静脉血栓形成发生率高支持了之前的研究。我们的研究结果可推广至其他西方国家。

研究经费/利益冲突:数据获取费用由丹麦中央大区医生继续教育秘书资助。作者均无任何利益冲突。

临床试验注册号

不适用。

相似文献

1
Increased venous thrombosis incidence in pregnancies after in vitro fertilization.体外受精后妊娠静脉血栓栓塞发病率增加。
Hum Reprod. 2014 Mar;29(3):611-7. doi: 10.1093/humrep/det458. Epub 2014 Jan 6.
2
Low risk of venous thromboembolism following early pregnancy loss in pregnancies conceived by IVF.体外受精妊娠中,早期妊娠丢失后静脉血栓栓塞风险较低。
Hum Reprod. 2018 Oct 1;33(10):1968-1972. doi: 10.1093/humrep/dey271.
3
The incidence of hypertensive disorders of pregnancy following sperm donation in IVF: an Australian state-wide retrospective cohort study.供精试管婴儿中妊娠高血压疾病的发生率:一项澳大利亚全州回顾性队列研究。
Hum Reprod. 2019 Dec 1;34(12):2541-2548. doi: 10.1093/humrep/dez198.
4
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂方案中严重卵巢过度刺激综合征的风险:一项纳入1050个首次体外受精/卵胞浆内单精子注射周期的随机对照试验
Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.
5
Increased risk of severe maternal morbidity in women with twin pregnancies resulting from oocyte donation.因卵母细胞捐赠导致双胎妊娠的女性发生严重孕产妇发病的风险增加。
Hum Reprod. 2020 Aug 1;35(8):1922-1932. doi: 10.1093/humrep/deaa108.
6
Severe maternal morbidity in women with high BMI in IVF and unassisted singleton pregnancies.体外受精和非辅助单胎妊娠中高 BMI 妇女的严重孕产妇发病率。
Hum Reprod. 2018 Aug 1;33(8):1548-1556. doi: 10.1093/humrep/dey224.
7
Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data.刺激与未刺激体外受精后的活产及围产期结局:基于全国范围二十多年数据的分析
Hum Reprod. 2016 Oct;31(10):2261-7. doi: 10.1093/humrep/dew184. Epub 2016 Sep 2.
8
Neonatal outcome and congenital malformations in children born after ICSI with testicular or epididymal sperm: a controlled national cohort study.经 ICSI 授精出生的睾丸或附睾精子后代的新生儿结局和先天性畸形:一项全国对照队列研究。
Hum Reprod. 2013 Jan;28(1):230-40. doi: 10.1093/humrep/des377. Epub 2012 Nov 15.
9
Obstetric and perinatal risks in 4601 singletons and 884 twins conceived after fresh blastocyst transfers: a Nordic study from the CoNARTaS group.4601 例单胎妊娠和 884 例双胎妊娠的产科和围生期风险:来自 CoNARTaS 组的北欧研究。
Hum Reprod. 2020 Apr 28;35(4):805-815. doi: 10.1093/humrep/deaa032.
10
Preterm delivery risk in infertile women who conceived after reproductive surgery: natural conception versus IVF/ICSI.生殖手术后不孕女性自然妊娠与 IVF/ICSI 妊娠的早产风险比较。
Hum Reprod. 2021 May 17;36(6):1630-1639. doi: 10.1093/humrep/deaa380.

引用本文的文献

1
Association between perinatal complications and venous thromboembolism in postpartum women.围产期并发症与产后女性静脉血栓栓塞之间的关联。
J Glob Health. 2025 May 16;15:04153. doi: 10.7189/jogh.15.04153.
2
Thromboprophylaxis and adult congenital heart disease: The latest on indications, risk scoring and therapy.血栓预防与成人先天性心脏病:关于适应证、风险评分及治疗的最新进展
Int J Cardiol Congenit Heart Dis. 2025 Jan 29;19:100570. doi: 10.1016/j.ijcchd.2025.100570. eCollection 2025 Mar.
3
Risk of Thrombosis in Women Undergoing In Vitro Fertilization: A Narrative Review.
接受体外受精的女性的血栓形成风险:一项叙述性综述。
J Clin Med. 2025 Feb 7;14(4):1053. doi: 10.3390/jcm14041053.
4
Change of HeART: Cardiovascular Implications of Assisted Reproductive Technology.心脏的改变:辅助生殖技术对心血管系统的影响
CJC Open. 2023 Sep 15;6(2Part B):142-152. doi: 10.1016/j.cjco.2023.09.008. eCollection 2024 Feb.
5
Managing Pulmonary Embolism With Right Ventricular Thrombus in In Vitro Fertilization-Related Pregnancy: A Clinical Insight.体外受精相关妊娠合并右心室血栓的肺栓塞管理:临床见解
Cureus. 2023 Dec 31;15(12):e51383. doi: 10.7759/cureus.51383. eCollection 2023 Dec.
6
Specific changes and clinical significance of plasma D-dimer during pregnancy and puerperium: a prospective study.血浆 D-二聚体在妊娠和产褥期的特定变化及临床意义:一项前瞻性研究。
BMC Pregnancy Childbirth. 2023 Apr 13;23(1):248. doi: 10.1186/s12884-023-05561-1.
7
Pulmonary Embolism After in vitro Fertilization and Cesarean Section: Two Case Reports and Brief Review of the Literature.体外受精与剖宫产术后发生肺栓塞:两例报告并文献简要回顾
Int J Womens Health. 2022 Oct 25;14:1489-1497. doi: 10.2147/IJWH.S366355. eCollection 2022.
8
Factors VIII and Von Willebrand Levels in Women Undergoing Assisted Reproduction: Are Their Levels Associated with Clinical Pregnancy Outcome?接受辅助生殖的女性的凝血因子VIII和血管性血友病因子水平:它们的水平与临床妊娠结局有关吗?
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020058. doi: 10.4084/MJHID.2020.058. eCollection 2020.
9
Hormones and thrombosis: risk across the reproductive years and beyond.激素与血栓:生殖年龄段及以后的风险。
Transl Res. 2020 Nov;225:9-19. doi: 10.1016/j.trsl.2020.06.011. Epub 2020 Jun 26.
10
Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature.低分子量肝素在孕期的应用:来自希腊的实践调查及文献综述
Thromb J. 2019 Dec 4;17:23. doi: 10.1186/s12959-019-0213-9. eCollection 2019.